Multiple Sclerosis Information
Search
I would appreciate a donation. I spend a lot of time every day in researching for articles and the latest research on MS. When an something is written in medical terminology I translate it into non-medical terms. I can no longer work because of my MS.
This Month
June 2009
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30
Main Page  »  Research  »  Research
View Article  Cognitive function Improved by disease-modifying therapies
Patients with relapsing-remitting multiple sclerosis (RRMS) who receive glatiramer acetate (GA) or interferon (IFN) beta show a reduction in cognitive impairment and relative stability of cognitive and affective variables at 2 years, according to the results of an observational study presented   more »
View Article  First Phase III results for FTY720
Initial results from the one-year Phase III TRANSFORMS study show the investigational oral compound FTY720 (fingolimod) has superior efficacy to a current standard of care for patients with relapsing-remitting multiple sclerosis (MS). Patients on oral FTY720 experienced significantly fewer relapses than those treated with   more »
View Article  Interferon Beta-1a 15-Year Long-Term Follow-up Study
The goal of the current study was to evaluate the effect of intramuscular interferon beta-1a therapy on long-term disability and quality-of-life outcomes in patients who had completed 2 or more years of the MSCRG trial, said Robert Bermel, MD, Mellen Center   more »
View Article  Adolescents process of separation from MS parents
The study examined the implications of responsibility and obligation on separation-individuation processes and the appearance of various symptoms of psychological distress in    more »
View Article  Patient Behaviors Depend Significantly On Level Of Health
Whether a patient has poor health or good health can affect his or her behaviours relating to physicians, taking prescription drugs, sources of health information and trust in health care    more »
View Article  BRAIN’S WHITE MATTER: MORE “TALKATIVE” THAN ONCE THOUGHT
Johns Hopkins scientists have discovered to their surprise that nerves in the mammalian brain’s white matter do more than just ferry information between different brain regions, but in fact process information the way gray matter    more »
View Article  Deactivating Protein May Protect Nerve Fibers In MS
Oregon Health & Science University neuroscientist researchers, working with colleagues at the Portland Veterans Affairs Medical Center and the University of Padova in Italy, have shown that genetically inactivating a protein called cyclophilin D can protect nerve    more »
View Article  Parasite Infection May Benefit MS Patients
A steady rise in autoimmune diseases such as multiple sclerosis (MS) has been noted in recent decades, and environmental factors could be the cause of this increase. One theory, similar to the "hygiene hypothesis" in which an excessively germ-free environment may contribute to    more »
View Article  Prevalence of edema of the lower limbs in MS
The aim of the study was to evaluate the frequency of edema of the lower limbs in multiple sclerosis (MS) patients utilizing a multidisciplinary approach.    more »
View Article  Study - Clustering of autoimmune diseases in families with a high-risk for MS
Autoimmune mechanisms are thought to have a major role in the pathogenesis of multiple sclerosis. We aimed to identify coexisting autoimmune phenotypes in patients with multiple sclerosis from families with several members with the disease and   more »
View Article  soy-based substance might help fight MS
A natural substance made from soy appears to have amazing restorative powers when given to animals with a multiple sclerosis (MS)-like disease   more »
View Article  importance of long-term data in multiple sclerosis
Natural history studies provide important information on the prognosis of multiple sclerosis and on risk factors for long-term outcome and thus help orientate treatment decisions and design clinical trials. Before the introduction of disease-modifying treatment, large longitudinal natural    more »
View Article  Eli Lilly and BioMS Medical's multiple sclerosis drug MBP8298.
MBP8298 is currently being evaluated in two pivotal Phase III clinical trials in secondary progressive MS (SPMS) and one Phase II trial in relapsing-remitting MS (RRMS). BioMS will    more »
View Article  Treatment of active secondary progressive multiple sclerosis (SPMS) with Treosulfan
Treosulfan (L-threitol-1,4-bis(methanesulfonate)) is a bifunctional alkylating agent with a favourable profile of side effects, approved for the treatment of ovarian cancer. Treosulfan has previously been shown to reduce the severity   more »
View Article  Which T cell types drive the autoimmune response in multiple sclerosis?
In multiple sclerosis (MS), the myelin that surrounds the axons of nerve cells is attacked by the body’s own T cells, resulting in slowed and disrupted    more »